Cancer diagnostics News and Research

RSS

Medical experts convene to discuss emotional and medical issues of young breast cancer survivors

One in eight women diagnosed with breast cancer is younger than 45 when diagnosed, yet their emotional and medical concerns are different than those of women over age 45, as is the impact of their diagnosis on family, friends, partners, colleagues and children.

18 Feb 2010

New conference to discuss issues surrounding breast cancer to take place at UWE

An opportunity to join a forum to discuss issues surrounding breast cancer is taking place at the University of the West of England on Saturday 3 July 2010.

15 Feb 2010

Research roundup: Bundled payments, PTSD incidence, cost of treating immigrants

This paper examines the spending for health care of adult naturalized citizens and immigrant noncitizens (including some undocumented immigrants) compared to U.S. natives, as documented in data from the 1999-2006 Medical Expenditure Panel Surveys (MEPS): "inflation and age-adjusted health care expenditures among noncitizen immigrants were consistently … lower than those of naturalized citizens and U.S. natives during 1999-2006."

15 Feb 2010

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.

10 Feb 2010

Clarient launches Clarient Insight Dx Pulmotype Test for lung cancer

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of a new lung cancer test, Clarient Insight® Dx Pulmotype® Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective.

10 Feb 2010

US HIFU announces exclusive partnership with Riverside Research Institute

US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research Institute (RRI) to develop and test an ultrasonic method of prostate imaging and treatment that combines advanced tissue-type imaging with ultrasound energy from the Sonablate® 500 medical device.

10 Feb 2010

Racial disparities continue in U.S. cancer screening practices

The incidence of advanced breast cancer diagnosis among black women remained 30 percent to 90 percent higher compared to white women between 1992 and 2004, according to new findings by researchers at Fred Hutchinson Cancer Research Center. In addition, the disparity in the incidence of advance colorectal cancer actually widened over this time period as rates fell among whites but increased slightly among blacks.

9 Feb 2010

Increased Medicare reimbursement leads to rise in outpatient bladder cancer surgeries

Increased Medicare payments to physicians for outpatient surgeries for bladder cancer have led to a dramatic rise in the number of these procedures being performed and an overall increase in cost to the healthcare system. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The findings indicate that some Medicare policies aimed at decreasing costs may instead be contributing to an increase in healthcare expenditures.

8 Feb 2010

Nearly 50% of essential services provided for cancer treatment not reimbursed by Medicare

A comprehensive study of the components of the delivery of modern-day cancer care in community oncology practices revealed that Medicare covers only 56% of the actual costs of administering chemotherapy and providing related infusion room services to seniors with cancer. The remaining costs -- for essential services provided such as treatment planning, care coordination, and follow-up care planning -- are not reimbursed by Medicare, causing many oncology practices to struggle to continue to provide care under the Medicare program.

5 Feb 2010

Regular exercise and drinking tea may reduce depression in breast cancer patients

Breast cancer patients who exercise and drink tea on a regular basis may be less likely to suffer from depression than other patients, according to a new study led by Xiao Ou Shu, M.D., Ph.D., professor of Medicine, Vanderbilt-Ingram Cancer Center. Xiaoli Chen, M.D., a post-doctoral fellow, was first author of the study published in the January issue of the Journal of Clinical Oncology.

28 Jan 2010

New research project aims at understanding the genetic origins of childhood cancers

St. Jude Children's Research Hospital and Washington University School of Medicine in St. Louis, today announced an unprecedented effort to identify the genetic changes that give rise to some of the world's deadliest childhood cancers.

27 Jan 2010

Biomoda applauds Senator for introducing legislative bill for lung cancer screening

Cancer diagnostics company Biomoda, Inc. (www.biomoda.com) today applauded Nebraska State Sen. Bob Krist and his co-sponsors for introducing legislation to screen up to 500 Nebraska veterans for early-stage lung cancer.

27 Jan 2010

Quest Diagnostics announces 2.8% increase in revenues for full-year 2009

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2009, income from continuing operations increased to $182 million, or $0.97 per diluted share, compared to $170 million, or $0.87 per diluted share, in 2008. The quarter included a $0.04 per share charge associated with the early extinguishment of debt, which was offset by certain non-recurring tax benefits totaling $0.04 per share.

From Quest Diagnostics 25 Jan 2010

Random lasers may prove useful for diagnosing cancer, say Utah researchers

When University of Utah scientists discovered a new kind of laser that was generated by an electrically conducting plastic or polymer, no one could explain how it worked and some doubted it was real.

24 Jan 2010

Ontario must stay the course in the fight against lung cancer

Currently an estimated 7,800 Ontarians are diagnosed with lung cancer and approximately 6,000 die of the disease each year. Smoking and exposure to second-hand smoke continue to be the main risk factors for developing lung cancer - and that is why we must continue to encourage Ontarians to be smoke-free.

21 Jan 2010

College of American Pathologists unveils resources and features on cancer in MyBiopsy.org

There's nothing more frightening than hearing the words "you have cancer" from your physician. With this diagnosis, many questions come to mind ... What's next? Will I survive? How do I tell my loved ones? The last is the most important for many people after receiving a cancer diagnosis: I need accurate information right now.

21 Jan 2010

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

AstraZeneca and Dako Denmark A/S announced today that they have entered into a collaboration agreement to develop companion diagnostic tests for multiple AstraZeneca oncology projects, including biologics and small molecules, in various stages of discovery and development.

18 Jan 2010

European approval for Abbott's new ovarian cancer diagnostic test

A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help in the assessment of epithelial ovarian cancer, the most lethal form of gynecological cancer.

14 Jan 2010

Abraxis Bioscience awards John Wayne Cancer Institute $1M grant for identifying new cancer biomarkers

A $1 million grant from Abraxis Bioscience, Inc. to a world-famous research laboratory at John Wayne Cancer Institute at Saint John’s Health Center could help save lives of cancer patients by helping doctors more rapidly assess whether a treatment is working or not.

12 Jan 2010

New blood test to identify changes in DNA linked with colorectal cancer now available in the U.S.

A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.

12 Jan 2010

Cancer diagnostics News and Research

Medical experts convene to discuss emotional and medical issues of young breast cancer survivors

New conference to discuss issues surrounding breast cancer to take place at UWE

Research roundup: Bundled payments, PTSD incidence, cost of treating immigrants

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Clarient launches Clarient Insight Dx Pulmotype Test for lung cancer

US HIFU announces exclusive partnership with Riverside Research Institute

Racial disparities continue in U.S. cancer screening practices

Increased Medicare reimbursement leads to rise in outpatient bladder cancer surgeries

Nearly 50% of essential services provided for cancer treatment not reimbursed by Medicare

Regular exercise and drinking tea may reduce depression in breast cancer patients

New research project aims at understanding the genetic origins of childhood cancers

Biomoda applauds Senator for introducing legislative bill for lung cancer screening

Quest Diagnostics announces 2.8% increase in revenues for full-year 2009

Random lasers may prove useful for diagnosing cancer, say Utah researchers

Ontario must stay the course in the fight against lung cancer

College of American Pathologists unveils resources and features on cancer in MyBiopsy.org

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

European approval for Abbott's new ovarian cancer diagnostic test

Abraxis Bioscience awards John Wayne Cancer Institute $1M grant for identifying new cancer biomarkers

New blood test to identify changes in DNA linked with colorectal cancer now available in the U.S.

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News